Abstract
Background: Pulsed field ablation (PFA) is a non-thermal energy source with promising safety and efficacy advantages. We aimed to develop a convenient, safe, effective and fast method of pulmonary vein isolation (PVI) utilizing a penta-spline PFA catheter via a single femoral vein and a venous closure system. Methods and Results: Consecutive patients (n=50; mean age: 63.6±10.7 years, 38% female) presenting with AF (paroxysmal AF: 56%) underwent first-time PVI via PFA. A single ultrasound-guided femoral vein puncture and a single transseptal puncture were used. After PVI using the penta-spline PFA catheter, extra pulse trains were added to the posterior wall for wide antral circumferential ablation. A venous closure system was used and a Donati suture was performed. The pressure bandage was removed after 1 h. A total of 196 PVs were identified and isolated with PFA only. The mean procedural time was 27.4±6.6 min, and the mean dwelling time was 14.4±5.5 min. Time to ambulation was 3.3±3.1 h. No severe complications occurred. During a mean follow-up of 6.5±2.1 months, 41/50 patients (82%) remained in sinus rhythm. Conclusions: The combination of a single venous puncture, single transseptal puncture approach using PFA and vascular closure device resulted in a 100% rate of acute PVI and an extraordinarily fast procedure and time to ambulation. The rate of periprocedural complications was low.
| Originalsprache | Englisch |
|---|---|
| Zeitschrift | Circulation Journal |
| Jahrgang | 87 |
| Ausgabenummer | 12 |
| Seiten (von - bis) | 1722-1726 |
| Seitenumfang | 5 |
| ISSN | 1346-9843 |
| DOIs | |
| Publikationsstatus | Veröffentlicht - 2023 |
Fördermittel
B.K. received travel and congress sponsoring from Biotronik, Abbott, Impulse Dynamics, and Pfizer, and speaker honoraria from Biotronik, Impulse Dynamics, C.T.I. GmbH and Doctrina Med. C.-H.H. received travel grants and research grants from Boston Scientific, Liftech, Biosense Webster and Cardiofocus, and speaker honoraria from Boston Scientific, Biosense Webster, Cardiofocus and C.T.I. GmbH and Doctrina Med. J.V. received speaker honoraria from Abbott, Boston Scientific, Impulse Dynamics, Pfizer and Doctrina Med. H.-L.P. received travel grants from Cardiofocus and C.T.I., and educational grants from Biosense Webster, all outside the submitted work. S.S.P. received travel and congress sponsoring from LifeTech outside the submitted work. R.R.T. is a consultant for Abbott, Boston Scientific, Biotronik and Biosense Webster, and received speaker honoraria from Biosense Webster, Medtronic, Boston Scientific and Abbot Medical. K.-H.K. reports grants and personal fees from Abbott Vascular, Medtronic, and Biosense Webster outside the submitted work. All other authors have no relevant disclosures.
UN SDGs
Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung
-
SDG 3 – Gesundheit und Wohlergehen
Strategische Forschungsbereiche und Zentren
- Zentren: Universitäres Herzzentrum Lübeck (UHZL)
DFG-Fachsystematik
- 2.22-12 Kardiologie, Angiologie
Fingerprint
Untersuchen Sie die Forschungsthemen von „Pulsed Field Ablation-Based Pulmonary Vein Isolation Using a Simplified Single-Access Single-Catheter Approach ― The Fast and Furious PFA Study ―“. Zusammen bilden sie einen einzigartigen Fingerprint.Zitieren
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver